October 16, 2025

Propanc Secures Up to $100M from Hexstone

Propanc Biopharma, a company that is developing treatments to stop cancer recurrence, has entered into a strategic financing agreement of up to $100 million with Hexstone Capital — an investment firm. The agreement begins with an initial $1 million …

About Author

Leave a Reply

Your email address will not be published. Required fields are marked *

Copyright ©CashBot.Club All rights reserved. | Newsphere by AF themes.